Literature DB >> 8542214

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment.

D D'Cruz1, A M Chesser, C Lightowler, M Comer, M J Hurst, L R Baker, A E Raine.   

Abstract

Two cases of antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis following treatment with propylthiouracil and carbimazole are described. Both patients had crescentic glomerulonephritis proven by renal biopsy and responded to immunosuppressive therapy and withdrawal of the anti-thyroid drugs. Though systemic vasculitis associated with propylthiouracil is reported, this is the first report to our knowledge of renal biopsy-proven vasculitis associated with either of these drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542214     DOI: 10.1093/rheumatology/34.11.1090

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  15 in total

Review 1.  Pathogenesis and treatment of ANCA-associated systemic vasculitis.

Authors:  A D Salama
Journal:  J R Soc Med       Date:  1999-09       Impact factor: 5.344

2.  Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis.

Authors:  Jörg Kaufmann; Eberhard Schulze; Ulrich Voigt; Jürgen Strobel; Gert Hein; Günter Stein
Journal:  Rheumatol Int       Date:  2003-04-17       Impact factor: 2.631

Review 3.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

4.  A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism.

Authors:  Turan Calhan; Ebubekir Senateş; Egemen Cebeci; Sayid Shafi Zuhur; Fatma Ozbakır; Uğur Görpe
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

5.  Proteinuria in a patient with Graves' disease: Questions.

Authors:  Aydilek Dagdeviren Cakir; Nur Canpolat; Seha Saygili; Isin Kilicaslan; Hande Turan; Oya Ercan; Olcay Evliyaoglu
Journal:  Pediatr Nephrol       Date:  2019-03-06       Impact factor: 3.714

6.  Proteinuria in a patient with Graves' disease: Answers.

Authors:  Aydilek Dagdeviren Cakir; Nur Canpolat; Seha Saygili; Isin Kilicaslan; Hande Turan; Oya Ercan; Olcay Evliyaoglu
Journal:  Pediatr Nephrol       Date:  2019-03-06       Impact factor: 3.714

Review 7.  C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab.

Authors:  Dayavathi Ashok; Shirish Dubey; Ian Tomlinson
Journal:  Clin Rheumatol       Date:  2007-08-22       Impact factor: 2.980

8.  Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen.

Authors:  Katrin S Reiners; Hinrich P Hansen; Anne Krüssmann; Gisela Schön; Elena Csernok; Wolfgang L Gross; Andreas Engert; Elke Pogge Von Strandmann
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

9.  Benzylthiouracil-induced glomerulonephritis.

Authors:  Sihem Trimeche Ajmi; Rim Braham; Sarra Toumi; Molka Chadli Chaieb; Amel Maaroufi; Koussay Ach; Larbi Chaieb
Journal:  Case Rep Med       Date:  2009-07-06

10.  Churg-Strauss Syndrome following PTU Treatment.

Authors:  R A M Quax; A J G Swaak; M G A Baggen
Journal:  Int J Rheumatol       Date:  2009-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.